American Journal of Cardiology
Volume 102, Issue 1 , Pages 12-18 , 1 July 2008

Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metalloproteinase-9 Activity in the Plasma of Patients With Non-ST-Elevation Acute Coronary Syndrome†

  • Almudena Gómez-Hernández, PhD

      Affiliations

    • Vascular Research Laboratory, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • ,
  • Eva Sánchez-Galán, BsC

      Affiliations

    • Vascular Research Laboratory, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • ,
  • Mónica Ortego, PhD

      Affiliations

    • Vascular Research Laboratory, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • ,
  • José Luis Martín-Ventura, PhD

      Affiliations

    • Vascular Research Laboratory, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • ,
  • Luis Miguel Blanco-Colio, PhD

      Affiliations

    • Vascular Research Laboratory, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • ,
  • Nieves Tarín-Vicente, MD

      Affiliations

    • Department of Cardiology, Hospital de Móstoles, Madrid, Spain
    • ,
  • José Julio Jiménez-Nacher, MD

      Affiliations

    • Department of Cardiology, Fundación Hospital de Alcorcón, Madrid, Spain
    • ,
  • Lorenzo López-Bescos, MD

      Affiliations

    • Department of Cardiology, Fundación Hospital de Alcorcón, Madrid, Spain
    • Rey Juan Carlos University, Madrid, Spain.
    • ,
  • Jesús Egido, MD

      Affiliations

    • Vascular Research Laboratory, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • ,
  • José Tuñón, MD

      Affiliations

    • Department of Cardiology, Fundación Jiménez Díaz and Autónoma University, Madrid, Spain
    • Corresponding Author InformationCorresponding author: Tel: 34-91-5504816; fax 34-91-5497033.

Received 18 December 2007 ,Revised 26 February 2008 ,Accepted 26 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by Grants PI050451, PI052475, and PI051043 from Fundación Española del Corazón, Fondo de Investigaciones Sanitarias; Grant SAF2007/63648 from Fundación Ramón Areces, Madrid, Spain; Sociedad Española de Arteriosclerosis, Barcelona, Spain; Spanish Ministerio de Ciencia y Tecnología; Grant S2006/GEN-0247 from Comunidad Autónoma de Madrid; and Pfizer, Madrid, Spain.

PII: S0002-9149(08)00438-4

doi: 10.1016/j.amjcard.2008.02.090

American Journal of Cardiology
Volume 102, Issue 1 , Pages 12-18 , 1 July 2008

Article Tools

* Image Usage & Resolution